Marine-derived Bioactive Peptides and Lipids Applied in Non-communicable Diseases
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (30 November 2018) | Viewed by 19180
Special Issue Editor
Interests: animal food quality and technology; functional marine food; fish lipids
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Non-communicable diseases, such as cardiovascular diseases, different types of cancer, respiratory diseases and diabetes, are the leading cause of death globally. Marine species are valuable source of bioactive constituents, such as peptides, proteins and lipids. Marine-derived biopeptides—due to their structural properties and their amino acids composition and sequences - exhibit various biological activities such as anti-atherosclerotic, anti-hypertensive, anti-cancer, anti-diabetic, anti-oxidative, anti-obesity activity, etc., preventing non-communicable diseases. Additionally, marine-derived bioactive lipids such as marine phosholipids have high content of the long-chain polyunsaturated omega-3 fatty acids EPA and DHA and exhibit numerous biological properties against atherosclerosis, thrombosis and inflammation. Therefore, the purpose of the current Special Issue is to publish novel ideas related to the therapeutic potential of marine-derived bioactive peptides and lipids in the treatment or prevention of non-communicable diseases, underlining the possible use of the aforementioned bioactive constituents as functional food ingredients, nutraceuticals or pharmaceuticals.
Dr. Constantina NasopoulouGuest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Marine species
- Marine-derived bioactive peptides
- Marine-derived bioactive phospholipids
- Non-communicable diseases
- Nutraceuticals
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.